Tikun Hemp

Tikun Hemp sells full-spectrum CBD tinctures, soft-gels, topicals and canine drops, all extracted from U.S.-grown hemp; most SKUs fall between $39 and $119, placing the line in the mid-to-premium tier. Products are sold direct-to-consumer through tikunhemp.com and ship to all 50 states; no brick-and-mortar distribution is listed. The brand licenses the genetics and research pedigree of Israel-based Tikun Olam, the medical-cannabis pioneer that has treated patients since 2005; every U.S. formula replicates the original strain profiles, including the high-CBD “Avidekel” clone that first reached 18% CBD with <1% THC. Third-party lab reports are batch-specific and QR-coded on every box, reinforcing a clinical, data-driven positioning. Core buyers are 30-55-year-old wellness seekers who want pharmaceutical-grade transparency without a prescription—especially professionals managing stress, inflammation or age-related discomfort and who favor evidence over lifestyle hype. The brand speaks to values of science, safety and functional wellness rather than recreational cannabis culture. Tikun Hemp competes in the crowded premium-CBD wellness space against brands that rely on celebrity endorsements or broad-spectrum isolates; it differentiates by importing time-tested Israeli genetics, publishing peer-reviewed studies on its strains, and keeping THC at or below the federal 0.3% limit while still offering a truly full-spectrum oil.